Brain Cancer Biobank
An enabling grant from the MHF has supported the establishment of a brain cancer biobank under the auspices of the Hunter Cancer Biobank housed at Hunter Medical Research Institute.
The Brain Cancer Biobank collects and stores samples donated by those who have been diagnosed with this disease. The samples will enable research into the causes and treatment of brain cancer.
The Brain Cancer Biobank contains:
The HCRA Biomarkers Flagship program has invested seed funding into the development of infrastructure to collect and store multiple samples of blood from patients diagnosed with cancer.The project is not only supported by the HCRA Biomarkers Flagship but has also attracted additional support from the Mark Hughes Foundation who are keen to see results from the SBC with respect to brain cancer research.Collections began in April 2015 with the appointment of a Biobank Liaison Officer to assist with patient consent and a part time technician to process blood samples for storage.
These samples are being collected as part of a feasibility study and selected studies and as such are not yet available for general distribution through the HCB.
Any solid tumour that is removed as part of a surgical procedure that is in excess to requirements for diagnosis of the patient is stored in the Brain Cancer Biobank as Formalin Fixed Paraffin Embedded (FFPE) blocks. These blocks can be sectioned onto slides to be used for research.
To obtain access to specimens from brain cancer patients for research please contact the HCB
Please contact us for access to FFPE samples held as part of the Brain Cancer Biobank.
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.